CANO FRANCIS

Average Profitability
22.59%
Insider Buys Quantity
9
Insider Buys Sum
$319,008.26
Insider Sells Quantity
3
Insider Sells Sum
$342,560.95

Insider Activity of CANO FRANCIS

According to the SEC Form 4 filings, CANO FRANCIS, being in a position of

  1. director at Dynavax Technologies Corporation,
    оver the last 12 months, has bought 0 shares, and sold 3615 shares for $43,127,
    over all time since 2011-08-05, has bought 73334 shares for $201,413, and sold 22615 shares for $342,561.

The largest purchase of all time was on 2011-08-05 and amounted to 40000 shares of Dynavax Technologies Corporation for $101,411.

The largest sale of all time was on 2022-08-08 and amounted to 15000 shares of Dynavax Technologies Corporation for $257,550.

Biography of CANO FRANCIS

No biography is available at this moment.

2024-05-31SaleDynavax Technologies Corporation
DVAX
director
3,615
0.0027%
$11.93$43,127-6.5%
2022-08-08SaleDynavax Technologies Corporation
DVAX
15,000
0.0116%
$17.17$257,550-35.21%
2019-08-12PurchaseDynavax Technologies Corporation
DVAX
director
33,334
0.0396%
$3.00$100,002+50.89%
2018-12-06SaleDynavax Technologies Corporation
DVAX
director
4,000
0.0063%
$10.47$41,884-46.96%
2018-01-25PurchaseBiomerica, Inc.
BMRA
director
8,200
0.0992%
$4.18$34,276-9.16%
2018-01-24PurchaseBiomerica, Inc.
BMRA
director
3,600
0.0419%
$4.18$15,048-12.38%
2016-08-09PurchaseBiomerica, Inc.
BMRA
director
4,300
0.0528%
$2.64$11,347-3.04%
2016-08-08PurchaseBiomerica, Inc.
BMRA
director
236
0.0028%
$2.53$597-3.04%
2016-08-05PurchaseBiomerica, Inc.
BMRA
director
11,200
0.1346%
$2.41$26,944+4.08%
2016-08-04PurchaseBiomerica, Inc.
BMRA
director
5,100
0.0603%
$2.28$11,633+8.05%
2011-08-05PurchaseDynavax Technologies Corporation
DVAX
director
40,000
0.0326%
$2.54$101,411+44.62%
2007-05-25PurchaseBiomerica, Inc.
BMRA
director
24,000
0.3976%
$0.74$17,750+94.67%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.